Prevention of Sacituzumab Govitecan-related Neutropenia in Patients With Metastatic Triple Negative Breast Cancer
Clinical trial NCT06616987 · RECRUITING
Trial details
- NCT number
- NCT06616987
- Sponsor
- Yeon Hee Park
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-03
- Primary completion
- 2027-06-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.